Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances Discipline Parisa Khan topic
No spam. Unsubscribe anytime.
Pharmacist Parisa Khan petitions Board to end probation after controlled‑substance allegations
Summary
Parisa Khan, a pharmacist who was part of two 2021 accusations tied to excessive controlled‑substance dispensing, told the Board of Pharmacy on Sept. 11 she has completed required continuing education and seeks early termination of a three‑year probation. Deputy AG raised concerns about the seriousness of the underlying misconduct.
Pharmacist Parisa Khan appeared before the California State Board of Pharmacy Sept. 11 seeking early termination of a three‑year probation imposed after two 2021 accusations alleging improper dispensing of controlled substances.
Deputy Attorney General Christina Jarvis summarized the record: the first accusation (Jan. 13, 2021) alleged gross negligence in excessive controlled‑substance dispensing, including multiple prescriptions for high‑strength oxycodone with cash payments and other “red flags.” The second accusation (Sept. 20, 2021) alleged petitioner personally dispensed at least 65 controlled‑substance prescriptions and more than 3,300 tablets on non‑compliant prescription documents. Jarvis said petitioner admitted the conduct as part of a stipulated settlement that imposed three years of probation effective April 28, 2023, and that Khan has paid $4,000 in investigation and prosecution costs.
Khan testified that she accepts responsibility, described completing about 42.75 hours of continuing education since probation began and said she has taken ethics and regulatory courses, cultural‑competency training and drug‑abuse prevention courses. She told the board she had worked primarily for independent pharmacies and said some of the problem pharmacies had high volumes of cash transactions and that she previously felt “naive” and unsure how to refuse suspicious prescriptions. Khan said she now would refuse problematic prescriptions and described recent instances where she declined or adjusted high‑dose opioid prescriptions after contacting prescribers.
Deputy AG Jarvis said the petition packet was thorough but urged caution: the underlying conduct was serious and the board must be satisfied Khan has been rehabilitated. The matter was submitted; the board took no immediate action during open session and moved to closed session to deliberate. Jarvis noted that some letters of recommendation in the packet were written by community and faith leaders who said they were unaware of the discipline when contacted by staff; Jarvis said that reduces their evidentiary weight.
The board will issue a written decision following closed‑session deliberations.
